Clinical Trials Update from NCI, January 2024

Clinical Trials Update from NCI, January 2024 https://content.govdelivery.com/accounts/USNIHNCI/bulletins/387d9d8?reqfrom=share Trial Results Support Adding Daratumumab to Initial Treatment for Multiple Myeloma https://www.cancer.gov/news-events/cancer-currents-blog/2024/multiple-myeloma-darzalex-plus-vrd?cid=eb_govdel Enzalutamide Gets Added Approval for Prostate Cancer That Hasn’t Spread https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-xtandi-prostate-cancer-psa-recurrence?cid=eb_govdel Toripalimab Becomes First Immunotherapy Drug Approved for Nasopharyngeal Cancer https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-toripalimab-nasopharyngeal-cancer?cid=eb_govdel Vivian's Story Proud Member of the Navajo Nation—and Clinical Trial Participant https://www.cancer.gov/research/participate/stories/vivian?cid=eb_govdel